Diseases and disorders we support
The Leukaemia Foundation supports people and their loved ones impacted by blood cancers and disorders.
There are over 120 types of blood cancer or disorders and we have compiled a list of the most commonly diagnosed that we support. If your diagnosis is not on this list, please contact us on 1800 620 420 or info@leukaemia.org.au to see how we can help you.
Amyloidosis
AA – secondary amyloidosis
AL – systemic amyloidosis
ATTR – familial amyloidotic polyneuropathy
ATTR – wild type – senile amyloidosis
Afib – mutated fibrinogen alpha chain
Blood disorders
Aplastic anaemia (AA)
Systemic mastocytosis
Paroxysmal nocturnal haemoglobinuria
POEMS syndrome
Langerhans Cell Histiocytosis (LCH)
Leukaemia
Acute myeloid leukaemia (AML)
Acute myelomonocytic leukaemia (AMML)
Acute lymphoblastic leukaemia (ALL)
Acute promyelocytic leukaemia (APML)
Chronic myeloid leukaemia (CML)
Chronic lymphocytic leukaemia (CLL)
- Richter’s syndrome
Hairy cell leukaemia
Biphenotypic leukaemia
Myeloid sarcoma (localised leukaemia)
Lymphoma (60+ sub-types, most common below)
Hodgkin lymphoma
- Nodular sclerosing HL
- Mixed cellularity HL
- Lymphocyte depleted HL
- Lymphocyte rich HL
- Nodular lymphocyte predominant HL
Non-Hodgkin lymphoma
B-Cell:
- Follicular
- Diffuse large B-cell (DLBCL)
- Burkitt’s
- Mantle cell
- Primary mediastinal B-cell (PMBCL)
- Primary cutaneous B-cell
- Small lymphocytic (SLL)
- Marginal zone
- MALT
- Lymphoplasmacytic / Waldenstrom’s macroglobulinaemia (WM)
- Double hit (DHL)
T-Cell / NK-Cell:
- Adult T-Cell leukaemic (ATLL)
- Anaplastic large cell (ALCL)
- Peripheral T-Cell
- Cutaneous T-Cell
- Mycosis fungoides
- Sézary syndrome
- Subcutaneous panniculitis-like T-Cell
- T-Lymphoblastic
Myelodysplasia
Myelodysplastic neoplasms (MDS) – The WHO classification system 2022, previously Myelodysplastic syndromes (MDS)
- MDS with low blasts and isolated 5q deletion (MDS-5q)
- MDS with low blasts and SF3B1 mutation (MDS-SF3B1)
- MDS with biallelic TP53 inactivation (MDS-biTP53)
- MDS with low blasts (MDS-LB)
- MDS, hypoplastic (MDS-h)
- MDS with increased blasts (MDS-IB1)
- MDS with increased blasts (MDS-IB2)
- MDS with fibrosis
Myeloma
Smouldering / indolent myeloma
IgG myeloma
IgA myeloma
Light chain myeloma
Monoclonal gammopathy of unknown significance (MGUS)
Multiple myeloma
Plasmacytoma (localised myeloma)
Osteosclerotic myeloma
Myeloproliferative neoplasms
Essential thrombocythaemia (ET)
Polycythaemia (Rubra) vera (PV)
Primary myelofibrosis (MF)
Chronic myelomonocytic leukaemia (CMML)
Juvenile myelomonocytic leukaemia (JMML)
Chronic neutrophilic leukaemia (CNL)
Chronic eosinophilic leukaemia (CEL)
Systemic mastocytosis (SM)
Last updated on July 24th, 2024
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.